SCHEMBL20124067

SCHEMBL20124067

CC(C)C1CCN(CCCNC(=N)N)C1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.37
TP53 P04637 2/20 0.37
USP2 O75604 1/20 0.36
BCHE P06276 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GNAI3 P08754 1/20 0.33
GNAO1 P09471 1/20 0.33
GNAI1 P63096 1/20 0.33
GAA P10253 1/20 0.33
LMNA P02545 1/20 0.32
RAD52 P43351 1/20 0.32
CYP1A2 P05177 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20124089 0.81 RAD52 (0.50) TP53BCHEGNAI3GNAO1GNAI1
SCHEMBL11981725 0.81 GNAI3 (0.36) SMN1; SMN2USP2BCHEGNAI3GNAO1
SCHEMBL11048 0.81 USP2 (0.39) USP2ALDH1A1GAAMEN1KMT2A
SCHEMBL11960430 0.77 SMN1; SMN2 (0.37) SMN1; SMN2TP53USP2BCHEALDH1A1
SCHEMBL11981726 0.76 SIGMAR1 (0.40) SMN1; SMN2BCHEGNAI3GNAO1GNAI1
SCHEMBL20124153 0.75 SIGMAR1 (0.39) SMN1; SMN2USP2BCHEGNAI3GNAO1
SCHEMBL16687691 0.75 SIGMAR1 (0.39) SMN1; SMN2USP2BCHEGNAI3GNAO1
SCHEMBL15837589 0.75 GBA1 (0.36) BCHEGNAI3GNAO1GNAI1LMNA
SCHEMBL2116367 0.75 GBA1 (0.36) BCHEGNAI3GNAO1GNAI1LMNA
SCHEMBL14685578 0.74 GNAI3 (0.43) GNAI3GNAO1GNAI1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488532-B1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MELINTA THERAPEUTICS INC (US) 2018-05-09 EP disclosed